SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-17-123213
Filing Date
2017-04-13
Accepted
2017-04-13 16:07:03
Documents
5
Effectiveness Date
2017-04-13

Document Format Files

Seq Description Document Type Size
1 DEFA14A d316413ddefa14a.htm DEFA14A 17469
2 GRAPHIC g316413na1.jpg GRAPHIC 105502
3 GRAPHIC g316413na2.jpg GRAPHIC 185049
4 GRAPHIC g316413na3.jpg GRAPHIC 56317
5 GRAPHIC g316413na4.jpg GRAPHIC 6491
  Complete submission text file 0001193125-17-123213.txt   496717
Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33137 | Film No.: 17760709
SIC: 2834 Pharmaceutical Preparations